1. Home
  2. INTS vs IFBD Comparison

INTS vs IFBD Comparison

Compare INTS & IFBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • IFBD
  • Stock Information
  • Founded
  • INTS 2012
  • IFBD 2001
  • Country
  • INTS United States
  • IFBD China
  • Employees
  • INTS N/A
  • IFBD N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • IFBD Computer Software: Prepackaged Software
  • Sector
  • INTS Health Care
  • IFBD Technology
  • Exchange
  • INTS Nasdaq
  • IFBD Nasdaq
  • Market Cap
  • INTS 9.4M
  • IFBD 8.4M
  • IPO Year
  • INTS 2023
  • IFBD 2021
  • Fundamental
  • Price
  • INTS $0.32
  • IFBD $1.05
  • Analyst Decision
  • INTS Strong Buy
  • IFBD
  • Analyst Count
  • INTS 3
  • IFBD 0
  • Target Price
  • INTS $8.50
  • IFBD N/A
  • AVG Volume (30 Days)
  • INTS 2.7M
  • IFBD 23.4K
  • Earning Date
  • INTS 08-07-2025
  • IFBD 01-01-0001
  • Dividend Yield
  • INTS N/A
  • IFBD N/A
  • EPS Growth
  • INTS N/A
  • IFBD N/A
  • EPS
  • INTS N/A
  • IFBD N/A
  • Revenue
  • INTS N/A
  • IFBD $1,437,848.00
  • Revenue This Year
  • INTS N/A
  • IFBD N/A
  • Revenue Next Year
  • INTS N/A
  • IFBD N/A
  • P/E Ratio
  • INTS N/A
  • IFBD N/A
  • Revenue Growth
  • INTS N/A
  • IFBD 413.52
  • 52 Week Low
  • INTS $0.26
  • IFBD $0.89
  • 52 Week High
  • INTS $5.10
  • IFBD $3.54
  • Technical
  • Relative Strength Index (RSI)
  • INTS 37.08
  • IFBD 50.08
  • Support Level
  • INTS $0.28
  • IFBD $1.00
  • Resistance Level
  • INTS $0.32
  • IFBD $1.06
  • Average True Range (ATR)
  • INTS 0.06
  • IFBD 0.05
  • MACD
  • INTS 0.01
  • IFBD 0.01
  • Stochastic Oscillator
  • INTS 7.43
  • IFBD 35.71

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About IFBD Infobird Co. Ltd

Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.

Share on Social Networks: